↓ Skip to main content

Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study

Overview of attention for article published in BMC Cancer, May 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
3 X users
peer_reviews
1 peer review site
facebook
1 Facebook page

Citations

dimensions_citation
48 Dimensions

Readers on

mendeley
63 Mendeley